News from alvogen A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

09 Apr, 2019, 09:02 BST Alvogen and Business Partners Obtain First European Approvals for Generic Ulipristal 5mg

Alvogen today announced that it has successfully concluded sixteen parallel registration procedures for Ulipristal tablets. Alvogen and its business...


20 Feb, 2019, 14:54 GMT Alvogen Launches Generic Equivalent to Suboxone® (Buprenorphine/Naloxone) Sublingual Film

Global pharmaceutical company, Alvogen, has launched its generic equivalent to Suboxone® sublingual film (buprenorphine hydrochloride/naloxone...


14 Feb, 2019, 11:08 GMT Alvogen și Lotus lansează primul medicament biosimilar generic al capsulelor tari de Revlimid™ în anumite state europene

Compania farmaceutică globală Alvogen a anunțat astăzi lansarea pe anumite piețe CEE pe care operează, inclusiv România, Croația, Bulgaria și statele ...


14 Feb, 2019, 08:24 GMT Alvogen i Lotus lansiraju prvi generički ekvivalent kapsulama Revlimid™ u odabranim europskim zemljama

Globalna farmaceutska tvrtka, Alvogen, danas je objavila lansiranje prvog generičkog ekvivalenta Revlimid™ (lenalidomida) u nizu svojih operativnih...


14 Feb, 2019, 08:23 GMT Alvogen и Lotus започват да предлагат първият генеричен еквивалент на капсулите Revlimid™ в избрани европейски държави

Световната фармацевтична компания Alvogen обяви днес, че започва да предлага първият генеричен еквивалент на Revlimid™ (леналидомид) на редица от...


13 Feb, 2019, 09:00 GMT Alvogen and Lotus Launch the First Generic Equivalent to Revlimid™ Capsules in Selected European Countries

Global pharmaceutical company, Alvogen, today announced the launch of the first generic equivalent of Revlimid™ (lenalidomide) in a range of its...